Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease
Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease
批准号:
10673924
负责人:
Samir Kaushik Shah
金额:
$14.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-07-31
关键词:
AffectAftercareAmericanAmputationBiologyBlood VesselsBypassCardiologyCardiovascular systemCaringCathetersClinical ResearchComplement 3Conflict (Psychology)DataDecision AidDecision MakingDevelopmentDiagnosisDialysis procedureDiseaseEnd stage renal failureEnvironmentFee-for-Service PlansFloridaFoundationsGangreneGeographyGoalsGrantGuidelinesHealth PersonnelHealth Services ResearchHemodialysisHospital ReferralsIncidenceInterventionKidney FailureKnowledgeLeadershipLearningLength of StayLifeLimb structureLiteratureManaged CareMedicareMedicare claimMedicineMentorsMentorshipMethodsMorbidity - disease rateNephrologyOperative Surgical ProceduresOutcomeOutcomes ResearchPainPain managementPatient-Centered CarePatient-Focused OutcomesPatientsPeripheral arterial diseasePersonsPhysiciansPopulationPopulation HeterogeneityPositioning AttributeProceduresProcessProviderRecommendationResearchResearch PersonnelResearch PriorityResourcesRestRisk FactorsSample SizeSelection for TreatmentsSocietiesStentsSymptomsTechniquesTrainingTreatment FactorTreatment outcomeUniversitiesVascular DiseasesWritingaccountable care organizationbeneficiarycare outcomescareercareer developmentclinical carecollegecomorbiditycritical limb Ischemiaexperiencefollow-upimprovedlarge datasetslimb lossmortalitymultidisciplinarynon-healing woundspreferenceprogramsrisk sharingsatisfactionshared decision makingskill acquisitionskillstreatment as usualtreatment choicewound care
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Amputation and mortality rates are extraordinarily high for patients living with both advanced peripheral
arterial disease, or critical limb ischemia (CLI), and end-stage renal disease (ESRD). Treatment choices for
patients with CLI include catheter-based procedures (e.g. vascular stenting), surgery (e.g. bypass), primary
amputation, or symptom control alone (e.g. pain management and wound care). Overall, CLI has dismal
outcomes with a 25% mortality and a 30% major amputation rate at one year from diagnosis. Limited data
suggest even worse outcomes for patients with ESRD – for example, approximately 50% mortality at 18
months. The existing literature on outcomes is limited by small sample sizes, short follow-up, and a focus on
only two of the treatment options, catheter-based interventions and surgery. Patients with ESRD and CLI are
often faced with difficult treatment decisions that are complicated by a lack of 1) robust real-world evidence on
outcomes and 2) clinical care guidelines. Shared decision-making often relies on these types of information.
ESRD is a life-limiting disease and treatment of CLI is resource-intensive. Nevertheless, there are no
existing cardiovascular or nephrology society guidelines regarding CLI treatment in patients with ESRD.
Knowledge of outcomes of CLI treatment in patients with ESRD, factors affecting CLI treatment selection, and
guidelines to direct care would unequivocally improve care by helping to align patient values and preferences
with treatment decisions. Owing to these gaps in knowledge, I propose a mixed methods approach using the
national Medicare data 2017-2019 to understand 1) factors affecting treatment selection, and 2) traditional and
patient-centered outcomes after treatment of CLI in patients with ESRD, complemented by 3) a Delphi panel of
expert health care providers and patients to help inform the establishment of care guidelines and identification
of research priorities.
In addition to helping develop critical data on patients with ESRD and CLI, this proposal will be an
essential step in my development as an independent investigator. My long-term career goals are to develop a
research program focusing on outcomes of treatment and decision-making surrounding peripheral arterial
disease. I hope to advance the field of vascular surgery health services research to improve patient outcomes
and aid physicians and patients in aligning decision-making with patient goals and values. This proposal will
immediately contribute to my short-term career objectives: increasing expertise with use of Medicare fee-for-
service claims data, understanding the practice of nephrology as it applies to ESRD and comorbid conditions
such as CLI, learning relevant advanced quantitative and qualitative techniques, and improving grant writing,
leadership, and other career development skills. This proposal will take place in the resource-rich environment
of the University of Florida College of Medicine under the guidance of an expert mentoring team.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
National Institutes of Health funding among vascular surgeons is rare.
美国国立卫生研究院对血管外科医生的资助很少。
DOI:
10.1016/j.jvs.2023.05.052
发表时间:
2023
期刊:
Journal of vascular surgery
影响因子:
4.3
作者:
[Mirzaie,AminA, Cooper,MicholA, Weaver,MLibby, Jacobs,ChristopherR, Cox,MorganL, Berceli,ScottA, Scali,SalvatoreT, Back,MartinR, Huber,ThomasS, Upchurch,GilbertR, Shah,SamirK]
通讯作者:
Shah,SamirK
Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease
-
批准号:10525416
-
项目类别:
-
资助金额:$17.44万
-
财政年份:2022
-
负责人:Samir Kaushik Shah
-
依托单位:
海外基金